AEM vs HUDI

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

HUDI presents as a classic value trap, characterized by a stable Piotroski F-Score of 4/9 but crippled by severe technical decay and negative growth. While the company maintains a strong liquidity position (Current Ratio 2.89) and trades at a deep discount to book value (P/B 0.22), it is unable to translate this into profitability or revenue growth. The combination of a 0/100 technical trend and a -78.2% five-year price collapse suggests that the market is pricing in a permanent impairment of capital despite the low debt levels.